Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Three-dimensional Vision Alteration in Parkinson Disease.

NCT01620164 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT01620164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01620164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Three-dimensional Vision Alteration in Parkinson Disease.
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2011
Completion date
June 30, 2014
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease